Alembic Pharma Gets USFDA Final Nod for Rivaroxaban Tablets 2.5–20 mg
15 May, 2025, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Rivaroxaban…
